Device type · KQO
Automated Urinalysis System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
KQO
Clinical Chemistry
Device class
Class I
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
21
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Automated Urinalysis System
- Product code
- KQO
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.2900
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for KQO
Latest FDA decisions
- URISCAN OPTIMA510(k)
K141874 · Decided May 28, 2015 · 321 days after receipt
Device type: Automated Urinalysis System (KQO) · Laboratory Medicine & Pathology
K142543 · Decided May 11, 2015 · 243 days after receipt
Device type: Automated Urinalysis System (KQO) · Laboratory Medicine & Pathology
Reports received
21
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
21
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 2 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 1 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 8 | 0 | 0 | 0 |
| Nov 24 | 4 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 2 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 1 | 1 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 2 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 3 | 0 | 0 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 4 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result6
- Computer Operating System Problem3
- Incorrect, Inadequate or Imprecise Result or Readings2
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions19
- Urinary Tract Infection2
- Insufficient Information1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- DxU 840m Iris, REF: C76947; DxU 850m Iris, REF: C49513Open, Classified
Z-0160-2027 · Started Aug 12, 2026 · Posted by FDA Oct 15, 2026
Reason given: The rinse-line check valve has a shorter service lifespan than originally expected and requires annual replacement to prevent lamina fluid leakage; however, the check valve replacement was excluded from the annual preventive maintenance (PM) requirements without adequate reliability evaluation. When the check valve is...
Cause as FDA categorized it: Component design/selection
Z-0161-2027 · Started Aug 12, 2026 · Posted by FDA Oct 15, 2026
Reason given: The rinse-line check valve has a shorter service lifespan than originally expected and requires annual replacement to prevent lamina fluid leakage; however, the check valve replacement was excluded from the annual preventive maintenance (PM) requirements without adequate reliability evaluation. When the check valve is...
Cause as FDA categorized it: Component design/selection
Z-1596-2023 · Started Apr 5, 2023 · Posted by FDA May 17, 2023
Reason given: Beckman Coulter has become aware of an intermittent issue in which the optional flag Previous Sample Had Sperm was enabled but not displayed so that a carryover event could have been investigated.
Cause as FDA categorized it: Under Investigation by firm
32 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.